Literature DB >> 1377315

Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.

B J Hunt, H C Segal, M Yacoub.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1377315

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  2 in total

Review 1.  A risk-benefit assessment of aprotinin in cardiac surgical procedures.

Authors:  W B Dobkowski; J M Murkin
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

2.  Reheparinisation requirements after cardiopulmonary bypass in patients treated with aprotinin.

Authors:  C R Bailey; A R Fisher; A K Wielogorski
Journal:  Br Heart J       Date:  1994-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.